Eagle Pharmaceuticals
EGRX
#10046
Rank
A$21.22 M
Marketcap
$1.64
Share price
0.00%
Change (1 day)
-81.93%
Change (1 year)

Eagle Pharmaceuticals (EGRX) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : A$0.24 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's total liabilities are A$0.24 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eagle Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$0.25 B137.94%
2021-12-31A$0.10 B22.01%
2020-12-31A$87.36 M-18.85%
2019-12-31A$0.10 B-2.56%
2018-12-31A$0.11 B-5.12%
2017-12-31A$0.11 B33.04%
2016-12-31A$87.53 M86.11%
2015-12-31A$47.03 M
2014-09-30A$23.3 M35.07%
2013-09-30A$17.25 M-16.85%
2012-09-30A$20.75 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$172.75 B 70,990.84%๐Ÿ‡บ๐Ÿ‡ธ USA
A$92.56 B 37,992.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$92.44 B 37,941.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$53.45 B 21,896.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$136.72 B 56,164.48%๐Ÿ‡บ๐Ÿ‡ธ USA
A$102.50 B 42,079.90%๐Ÿ‡บ๐Ÿ‡ธ USA
A$121.22 B 49,784.80%๐Ÿ‡บ๐Ÿ‡ธ USA